Norway vs Sri Lanka: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Norway
95.0%
in 2025
Sri Lanka
95.0%
in 2025
Norway rank
29th
Sri Lanka rank
29th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Norway
- Sri Lanka
How they compare
Norway currently reports 95.0% against 95.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was Norway ahead.
Norway ranks 29th and Sri Lanka ranks 29th of 194 countries.
Across the 3 decades both report, Norway averaged higher in 1 and Sri Lanka in 2.
Head to head by decade
| Decade | Norway | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.5% | 81.7% | 9.8% | Norway |
| 2010s | 92.6% | 99.0% | 6.4% | Sri Lanka |
| 2020s | 94.5% | 97.2% | 2.7% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Norway or Sri Lanka?
- Norway, at 95.0% against 95.0% in Sri Lanka as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Norway and Sri Lanka?
- 0.0%, with Norway ahead.
- How many years of comparable data are there for Norway and Sri Lanka?
- 26 years are reported by both, from 2000 to 2025.
- How do Norway and Sri Lanka rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Norway ranks 29th and Sri Lanka ranks 29th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.